VANCOUVER, British Columbia, Jan. 18, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the ...
Unique solution enabling researchers to profile human oral drug bioavailability in vitro, in their own laboratories Expands access to CN Bio’s robust multi-organ Gut/Liver-on-a-chip model to ...
Cefdinir showed nearly double the treatment failure rate compared to cephalexin in outpatient uUTI management. Cefdinir's lower bioavailability and urinary excretion contribute to its reduced efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback